lenacapavir 300 MG Oral Tablet
RxNorm concept 2625890, clinical drug (scd).
- RxCUI
- 2625890
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2625890 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
lenacapavir 300 MG (as lenacapavir sodium 306.8 MG) Oral Tablet
Related concepts
- lenacapavir 300 MG (SCDC, consists of)
- {4 (lenacapavir 300 MG Oral Tablet) } Pack (GPCK, contained in)
- {5 (lenacapavir 300 MG Oral Tablet) } Pack (GPCK, contained in)
- Oral Tablet (DF, has dose form)
- lenacapavir 300 MG Oral Tablet [Sunlenca] (SBD, has tradename)
- lenacapavir 300 MG Oral Tablet [Yeztugo] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2625890 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2625890 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2625890. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.